Spike Protein Kda

Lab Reagents

Human IgG antibody Laboratories manufactures the spike protein kda reagents distributed by Genprice. The Spike Protein Kda reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: Kda

Kda information

SARS Spike Antibody
20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

Spike Glycoprotein Antibody
20-abx300551
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Acids Matrix Spike
CLPS-MSA 1ML
EUR 120.84

TCLP Volatiles Spike
TCLP-VX 1ML
EUR 106.02

Recombinant (Sf9) Purified MERS Spike protein ECD (1-1297 a.a, His-tag, ~157 kda, low Endotoxin)
MERSS126-R-10 10 ug
EUR 416.4

Recombinant (E. coli) Purified MERS-CoV Spike protein S1 (18-524 a.a, His-tag, ~62 kda)
MERSS17-R-10 10 ug
EUR 416.4

Recombinant (E. coli) Hepatitis virus (MHV/Coronavirs) Spike Protein S1 (>95% pure, His-tag, ~63 kda)
MHVS15-R-10 10 ug
EUR 489.6

SARS Biotinylated Spike RBD Recombinant Protein
10-212 0.1 mg
EUR 752.1
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Sars-Cov, Spike (Middle) Recom Protein
abx060656-1mg 1 mg
EUR 2030.4

SARS Associated Spike Mosaic S Protein
20-abx260156
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Anti-MERSC-CoV Spike Protein antibody
STJ140102 150 µg
EUR 277.2
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases.

Recombinant SARS Spike gp C Protein
VAng-Lsx0072-inquire inquire Ask for price
Description: SARS Spike glycoprotein C, recombinant protein from E. coli.

CLP ILM 02.0
SPIKE-1 125ML
EUR 303.24

CLP ISM 01.2 and ILM 05.3
SPIKE-4 125ML
EUR 336.3

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.